Loading the player...


INFO:
Ruben A. Mesa, M.D., discusses how the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis.
Drug can diminish the symptoms and burden of myelofibrosis - Mayo Clinic